Proteins & Enzymes for Cell Therapy

MHC Complexes, CAR-T Targets, VLPs, Cytokines, and Laminin 521 ProductsCAR-T TargetsCytokinesSoluble TCR Expression ServicesMHC Tetramers & MonomersPeptide-ready MHCsHLA-G and LILRsLaminin Read More...

Base editing technology leads a new chapter in drug development

View All Products Since its debut in 2016, base editing technology has opened up new perspectives and methods for drug Read More...

MSLN Targeted Drugs Entering the Fast Lane

View All Products Since December 2023, there have been several positive updates about drugs targeting MSLN. On December 19th, RemeGen Read More...

Exploring the Role of MICA in Tumor Immunity and Targeted Therapies

Contact UsView All Products MICA, also known as MHC Class I Polypeptide-Related Sequence A, is a type I MHC molecule Read More...

New advances in CRISPR gene therapy drugs

Contact UsView All Products On April 3, 2023, Vertex Pharmaceuticals and CRISPR Therapeutics announced the completion of the rolling biologics Read More...

Potential Immunotherapy Target TM4SF1

Contact Us View All Products TM4SF1 (Transmembrane 4L six family member 1) is a member of the TM4SF subfamily in Read More...

CDH17: A Safe CAR-T Target for Treatment of Solid Tumors

Contact Us View All Products Chimeric antigen receptor T cell (CAR-T) therapy has been successful in the field of hematological Read More...

GDF15-GFRAL breaks into the new drug track

Contact UsView All Products A variety of metabolic diseases that plague today's society, such as obesity, diabetes, cancer, etc., have Read More...

The culprit of cancer metastasis – uPAR-uPA

Contact UsView All Products Tumor invasion and metastasis are key risk factors for tumor recurrence and patient death. Tumor invasion Read More...